Aurora Cannabis (ACB) Investment Income (2017 - 2018)
Aurora Cannabis (ACB) posted quarterly Investment Income of -$2.5 million for Q3 2018, down 77988.94% year-on-year from N/an in Q3 2017, and down 77988.94% on a QoQ basis from -$3189.6 in Q3 2017.
Aurora Cannabis (ACB) Investment Income (2017 - 2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Investment Income for 2 consecutive years, with -$2.5 million the latest figure, recorded in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 153.98 Mn | 68.73 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -2.49 Mn |
| Sep 30, 2017 | -3,189.63 |